Apr 8, 2026 8:30am EDT RenovoRx Secures First Notice of Allowance for Japanese Patent Covering its RenovoCath® Device for Targeted, Local Drug-Delivery via the Vasa Vasorum
Apr 1, 2026 2:20pm EDT RenovoRx Named to Fast Company’s Annual List of the World’s Most Innovative Companies of 2026
